PubMed · 2024

Cagrilintide: A Long-Acting Amylin Analog for the Treatment of Obesity

D'Ascanio AM, Mullally JA, Frishman WH (2024). Cagrilintide: A Long-Acting Amylin Analog for the Treatment of Obesity. Cardiology in review.

Cardiology in review

Source: https://pubmed.ncbi.nlm.nih.gov/36883831/

Last reviewed July 14, 2026. By the PeptIQ team.

View original source

Peptides linked in PeptIQ Wiki

Cagrilintide — community report

This page indexes a published source for discovery and cross-linking. PeptIQ reports what the literature contains and what users track — it does not interpret studies as treatment guidance.